Published: October 07, 2008
Collagen Matrix, Inc. Launches Enhanced Web Site Featuring Innovative Collagen- and Mineral-Based Technology for Applications in Tissue Repair and Regeneration
FRANKLIN LAKES, N.J., Oct. 7 /PRNewswire/ -- Collagen Matrix, Inc., the
leader in the design and engineering of innovative collagen- and mineral-based
extracellular matrices for tissue and organ repair and regeneration, announced
today the launch of its newly updated web site, www.collagenmatrix.com to
provide the latest news and information to customers, distributors, marketing
partners, medical and healthcare professionals. The company maintains a
manufacturing facility, quality control laboratory, research and development
laboratory and warehouse inFranklin Lakes, New Jersey. Since its inception
in 1997, Collagen Matrix, Inc. has received many government grants for the
development of collagen-based matrix products in the areas of neurological,
vascular, urological, and orthopaedic tissue regeneration applications.
Over the past eleven years, the Company's growth has been steady and
significant with the emergence of its resorbable collagen membranes and
anorganic bone mineral products as the preferred products used in dental bone
grafting procedures. The addition of products focused on neurosurgery such as
NeuroMatrix(TM) and Neuroflex(TM) Collagen Nerve Conduits for the treatment of
severed peripheral nerves and NeuroMend(TM) Collagen Wrap Conduits for the
treatment of crushed, stretched, partially-severed or compressed peripheral
nerves, and DuraMatrix(TM) Collagen Dura Substitute Membrane for the repair of
dural mater has fueled the growth and created relationships with some of the
largest medical device companies in the world. Additional products that were
developed are OssiPatch(TM) Collagen Bone Healing Protective Sheet for bone
repair procedures, Collatene(TM) Microfibrillar Collagen Dental Wound Dressing
as well as several additional Wound Dressing products.
The recent worldwide launches of new products OssiMend(TM) Bone Graft
Matrix, OssiMend(TM) Putty Bone Graft Matrix, OssiGuide(TM) Cancellous
Granules, SynOss(TM) Synthetic Bone Graft Material, TenoMend(TM) Collagen
Tendon Wrap, and DuraMatrix-Onlay(TM) Conformable Collagen Dura Substitute
Membrane have expanded the Company's technology within the areas of
orthopaedic/spine surgery and neurosurgery for tissue repair and regeneration.
The increase in the Company's product portfolio led to significant facility
expansions to accommodate the rapid growth.
Collagen Matrix continues its focus in three healthcare fields:
Oral/Maxillofacial surgery, Neurosurgery and Orthopaedic/Spine surgery. A
pipeline of products has been identified for each area to expand the current
product portfolio in the years to come.
"The potential for our core collagen, mineral, and composite technology is
unlimited in the healthcare field extending beyond our current areas of focus.
The Company's proprietary technology is based on the science of hard and soft
tissue repair and regeneration. The combined experience and knowledge of the
Collagen Matrix team brings the science and technology to life through
innovative biological products for use in treating disease or injury in the
areas of regenerative medicine. We are looking forward to continued growth
and expansion of our company as we head into 2009 and beyond," said Shu-Tung
Li, Ph.D. Founder & CEO of Collagen Matrix.
Contact: Peggy Hansen, RAC
Sr. Director, Clinical, Regulatory, and Quality Assurance
201-405-1477, x204
SOURCE Collagen Matrix, Inc.
Copyright © 2012, PRNewswire
Copyright © 2012, NewsBlaze,
Daily News
Search News
